John Hancock Multifactor Healthcare ETF (JHMH)
| Assets | $44.08M |
| NAV | $47.91 |
| Expense Ratio | 0.40% |
| PE Ratio | 23.85 |
| Shares Out | 920,000 |
| Dividend (ttm) | $0.38 |
| Dividend Yield | 0.78% |
| Ex-Dividend Date | Dec 27, 2021 |
| 1-Year Return | +5.09% |
| Volume | 2,977 |
| Open | 48.38 |
| Previous Close | 47.66 |
| Day's Range | 47.91 - 48.40 |
| 52-Week Low | 41.40 |
| 52-Week High | 41.40 |
| Beta | 0.80 |
| Holdings | 139 |
| Inception Date | Sep 29, 2015 |
About JHMH
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. company at the time of reconstitution. The fund is non-diversified.
Top 10 Holdings
34.45% of assets| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 6.11% |
| UnitedHealth Group | UNH | 6.01% |
| Pfizer | PFE | 4.15% |
| Thermo Fisher Scientific | TMO | 3.25% |
| AbbVie | ABBV | 2.76% |
| Merck & Co. | MRK | 2.71% |
| Abbott Laboratories | ABT | 2.50% |
| Eli Lilly and Company | LLY | 2.44% |
| Bristol-Myers Squibb Company | BMY | 2.30% |
| Danaher | DHR | 2.22% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2021 | $0.20781 | Dec 30, 2021 |
| Jun 25, 2021 | $0.16726 | Jun 30, 2021 |
| Dec 24, 2020 | $0.64304 | Dec 30, 2020 |
| Jun 25, 2020 | $0.44983 | Jun 30, 2020 |
| Dec 24, 2019 | $0.23925 | Dec 30, 2019 |
| Jun 25, 2019 | $0.67124 | Jun 28, 2019 |
News
Cracking Open Factors: Beyond the Style Box
While 2020 may feel like a “this time it's different” year, the reality is the core underpinnings of what makes for a winning portfolio haven't changed: controlling expenses, managing your taxes, and mo...
Smart Beta ETFs to Better Engage with Current Markets
As more take a harder look at their portfolio composition, many investors are turning to smart beta exchange traded funds to enhance their portfolios and meet the challenges ahead. “They’re kind of real...